Prevalence of multidrug-resistant Staphylococcus aureus in diabetics clinical samples

World Journal of Microbiology and Biotechnology

Volumn 26, Issue 1, 2010, Pages 171-176

  Raju, S ^a,c   Oli, Ajay Kumar ^a   Patil, S A ^b   Chandrakanth, R Kelmani ^a  

^a GULBARGA UNIVERSITY   (India)

^b NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^c INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

Aminoglycoside modifying enzymes; mecA and femA; Methicillin resistant Staphylococcus aureus

Indexed keywords

AMINOGLYCOSIDE MODIFYING ENZYMES; AMINOGLYCOSIDE RESISTANCE; AMINOGLYCOSIDES; ANTIBIOTIC RESISTANCE; CIPROFLOXACIN; CLINICAL ISOLATES; CLINICAL SAMPLES; CODING GENES; DIABETIC PATIENT; LOW RESISTANCE; METHICILLIN; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; RESISTANT STAPHYLOCOCCUS AUREUS; S. AUREUS; STAPHYLOCOCCUS AUREUS; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTICS; CATALYSTS; ENZYMES; SULFUR COMPOUNDS;

GENES;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 77951100636     PISSN: 09593993     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11274-009-0157-5     Document Type: Article

References (24)

1. Anupurba S, Sen MR, Nath G, Sharma BM, Gulati AK, Mohapatra TM (2003) Prevalence of methicillin resistant Staphylococcus aureus in a tertiary referral hospital in eastern Uttar Pradesh. Indian J Med Microbiol 21: 49-51.
2. Arakere G, Nadig S, Swedberg G, Macaden R, Amarnath SK, Raghunath D (2005) Genotyping of methicillin-resistant Staphylococcus aureus strains from two hospitals in Bangalore, South India. J Clin Microbiol l43: 3198-3202.
3. CLSI (2009) Performance standard for antimicrobial susceptibility testing M100-S19.
4. Cottagnoud P, Cottagnoud M, Tauber MG (2003) Vancomycin acts synergistically with gentamycin against penicillin-resistant Pneumococci by increasing the intracellular penetration of gentamycin. Antimicrob Agents Chemother 47: 144-147.
5. Cui L, Ma X, Sato K, Okuma K, Tenover FC, Mamizuka EM, Gemmell CG, Kim M-N, Ploy M-C, Solh NE, Ferraz V, Hiramatsu K (2003) Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J Clin Microbiol 41: 5-14.
6. Dang CN, Prasad YDM, Boulton AJM, Jude EB (2002) Methicillin resistant Staphylococcus aureus in the diabetic foot clinic: the problem is getting worse. Diabetologica 45: A4.
7. Goldstein EJ, Citron DM, Nesbit CA (1996) Diabetic foot infections, bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive cases. Diabetes Care 19: 638-641.
8. Gresham HD, Lowrance JH, Caver TE, Wilson BS, Cheung AL, Lindberg FP (2000) Survival of Staphylococcus aureus inside neutrophils contributes to infection. J Immunol 164: 3713-3722.
9. Heurtier-Hartemann AJ, Robert S, Jacqueminet G, van H, Golmard JL, Jarlier V, Grimaldi A (2004) Diabetic foot ulcer and -resistant organisms: risk factors and impact. Diabetic Med 21: 710-715.
10. Ida T, Okamoto R, Shimauchi C, Okubo T, Kuga A, Inoue M (2001) Identification of aminoglycoside-modifying enzymes by susceptibility testing: epidemiology of methicillin-resistant Staphylococcus aureus in Japan. J Clin Microbiol 39: 3115-3121.
11. Jeremy R, Lee JC (2005) The pathogenesis of Staphylococcus aureus infection in the diabetic NOD mouse. Diabetes 54: 2904-2910.
12. Kao SJ, You IL, Clewell DB, Donabedian SM, Zervos MJ, Petrin J, Shaw KJ, Chow JW (2000) Detection of the high-level aminoglycoside resistance gene aph(2″)-Ib in Enterococcus faecium. Antimicrob Agents Chemother 44: 2876-2879.
13. Karchmer A (2002) Microbiology and treatment of diabetic foot infections. In: Veves A, Giurini JM, LoGerfro FW (eds) The diabetic foot: medical and surgical treatment. Humana, Totowa, NJ, pp 207-219.
14. Kelmani Chandrakanth R, Raju S, Patil SA (2008) Aminoglycoside resistance mechanisms in multi-drug resistant Staphylococcus aureus clinical isolates. Curr Microbiol 56: 558-562.
15. Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339(8): 520-532.
16. McMahon MM, Bistrian BR (1995) Host defenses and susceptibility to infection in patients with diabetes mellitus. Infect Dis Clin North Am 9: 1-9.
17. Mulligan ME, Murray-Leisure A, Ribner BS, Standiford HC, John JF, Korvick JA et al (1993) Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis and epidemiology with implications for prevention and management. Am J Med 94: 313-328.
18. Nadig S, Namburi P, Raghunath D, Arakere G (2006) Genotyping of methicillin-resistant Staphylococcus aureus isolates from Indian hospitals. Curr Sci 91: 1364-1369.
19. Poole K (2005) Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 49: 479-487.
20. Raju S, Kelmani Chandrakanth R, Patil SA (2007) High level oxacillin and gentamycin resistance with reduced susceptibility to vancomycin in Staphylococcus aureus carrying mecA and femA gene complex. Cur Microbiol 54: 429-434.
21. Roghmann MC, Siddiqui A, Plaisance K, Standiford H (2001) MRSA colonisation and the risk of MRSA bacteraemia in hospitalized patients with chronic ulcers. J Hosp Infect 47: 98-103.
22. Tentolouris N, Jude EB, Smirnof I, Knowles A, Boulton AJM (1999) Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic. Diabet Med 16: 767-771.
23. Tsao S-M, Hsu C-C, Yin M-C (2006) Methicillin-resistant Staphylococcus aureus infection in diabetic mice enhanced inflammation and coagulation. J Med Microbiol 55: 379-385.
24. Wu SW, De Lencastre H, Tomasz A (2001) Recruitment of the mecA gene homologue of Staphylococcus sciuri into a resistance determinant and expression of the resistant phenotype in Staphylococcus aureus. J Bacteriol 183: 2417-2424.